These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 202421

  • 1. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
    Ballantyne D, Ballantyne FC, Stromberg P, Third JL, Bedford DK.
    Clin Chim Acta; 1978 Feb 01; 83(1-2):117-22. PubMed ID: 202421
    [Abstract] [Full Text] [Related]

  • 2. The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects.
    Stromber P, Ballantyne D, Ballantyne FC, Third JL, Bedford DK.
    Clin Chim Acta; 1977 Aug 15; 79(1):163-72. PubMed ID: 196790
    [Abstract] [Full Text] [Related]

  • 3. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P, Schwandt P.
    Klin Wochenschr; 1977 Aug 15; 55(16):791-4. PubMed ID: 198601
    [Abstract] [Full Text] [Related]

  • 4. Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia.
    Ballantyne FC, Bedford DK, Ballantyne D, Third JL, Stromberg P, Packard CJ.
    Clin Chim Acta; 1977 Mar 15; 75(3):487-90. PubMed ID: 192494
    [Abstract] [Full Text] [Related]

  • 5. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB.
    Am J Med; 1979 Feb 15; 66(2):303-10. PubMed ID: 218451
    [No Abstract] [Full Text] [Related]

  • 6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Feb 15; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 7. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B, Hedstrand H, Olsson U.
    Ups J Med Sci; 1976 Feb 15; 81(2):71-8. PubMed ID: 183321
    [Abstract] [Full Text] [Related]

  • 8. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG, Lang PD.
    Atherosclerosis; 1978 Dec 15; 31(4):429-33. PubMed ID: 215175
    [Abstract] [Full Text] [Related]

  • 9. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
    Carlson LA, Olsson G, Ballantyne D.
    Atherosclerosis; 1977 Apr 15; 26(4):603-9. PubMed ID: 193526
    [Abstract] [Full Text] [Related]

  • 10. Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.
    Carlson K, Carlson LA.
    Scand J Clin Lab Invest; 1975 Nov 15; 35(7):655-60. PubMed ID: 174185
    [Abstract] [Full Text] [Related]

  • 11. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG, Lavy A, Aviram M, Zinder O.
    Atherosclerosis; 1980 Aug 15; 36(4):461-9. PubMed ID: 7417365
    [Abstract] [Full Text] [Related]

  • 12. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG, Haft GK, Juliano J.
    Atherosclerosis; 1976 Aug 15; 23(3):413-27. PubMed ID: 178325
    [Abstract] [Full Text] [Related]

  • 13. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
    Olsson AG, Lang PD.
    Atherosclerosis; 1978 Dec 15; 31(4):421-8. PubMed ID: 215174
    [Abstract] [Full Text] [Related]

  • 14. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN, Ghosh P.
    Proc R Soc Med; 1976 Dec 15; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [Abstract] [Full Text] [Related]

  • 15. Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
    Packard CJ, Shepherd J, Joerns S, Gotto AM, Taunton OD.
    Biochim Biophys Acta; 1979 Feb 26; 572(2):269-82. PubMed ID: 218633
    [Abstract] [Full Text] [Related]

  • 16. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA, Penttilä IM, Lampainen E.
    Acta Med Scand; 1972 Sep 26; 192(3):177-82. PubMed ID: 4341290
    [No Abstract] [Full Text] [Related]

  • 17. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B, Lithell H, Gustafsson IB, Borberg J.
    Atherosclerosis; 1979 Aug 26; 33(4):457-77. PubMed ID: 228684
    [Abstract] [Full Text] [Related]

  • 18. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER, Bierman EL.
    J Lab Clin Med; 1975 Aug 26; 86(2):239-52. PubMed ID: 168277
    [Abstract] [Full Text] [Related]

  • 19. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

  • 20. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1984 May 04; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.